Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP
NCT07497620
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Pityriasis Rubra Pilaris
Interventions
DRUG:
Bimekizumab
Sponsor
Mayo Clinic